Max Serrano-Wu
InvestorAnalyst at HEALTHCARE ROYALTY PARTNERS
About
Max Serrano-Wu is an Analyst at HCRx, where he supports transaction-related work such as financial analysis, transaction structuring, and due diligence, as well as business development. Before HCRx, he worked in life science consulting at Trinity Life Sciences, advising biopharmaceutical clients on commercial strategy, market opportunity, competitive landscape, market access, and brand growth. He holds a BA with Honors in Human Developmental and Regenerative Biology from Harvard College.
Colleagues at HEALTHCARE ROYALTY PARTNERS
Aaron B. Simon
Associate at HEALTHCARE ROYALTY PARTNERS
Amy J. Zacharias
Senior Vice President and Controller at HEALTHCARE ROYALTY PARTNERS
Andrew Logerfo
Vice President at HEALTHCARE ROYALTY PARTNERS
Carlos M. Almodóvar
Chief Business Officer at HEALTHCARE ROYALTY PARTNERS
Christopher A. White
President and Chief Financial Officer at HEALTHCARE ROYALTY PARTNERS
Clarke B. Futch
Chairman and Chief Executive Officer at HEALTHCARE ROYALTY PARTNERS
David Oron
Analyst at HEALTHCARE ROYALTY PARTNERS
Eric Yoo
Vice President, PharmD at HEALTHCARE ROYALTY PARTNERS
Frequently asked questions
- Who is Max Serrano-Wu?
- Max Serrano-Wu is an Analyst at HCRx, where he supports transaction-related work such as financial analysis, transaction structuring, and due diligence, as well as business development. Before HCRx, he worked in life science consulting at Trinity Life Sciences, advising biopharmaceutical clients on commercial strategy, market opportunity, competitive landscape, market access, and brand growth. He holds a BA with Honors in Human Developmental and Regenerative Biology from Harvard College.
- Where does Max Serrano-Wu work?
- Max Serrano-Wu is Analyst at HEALTHCARE ROYALTY PARTNERS.